|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EFTUD2-GNL2 (FusionGDB2 ID:25395) |
Fusion Gene Summary for EFTUD2-GNL2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EFTUD2-GNL2 | Fusion gene ID: 25395 | Hgene | Tgene | Gene symbol | EFTUD2 | GNL2 | Gene ID | 9343 | 29889 |
| Gene name | elongation factor Tu GTP binding domain containing 2 | G protein nucleolar 2 | |
| Synonyms | MFDGA|MFDM|SNRNP116|Snrp116|Snu114|U5-116KD | HUMAUANTIG|NGP1|Ngp-1|Nog2|Nug2 | |
| Cytomap | 17q21.31 | 1p34.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 116 kDa U5 small nuclear ribonucleoprotein componentSNU114 homologU5 snRNP-specific protein, 116 kDaelongation factor Tu GTP-binding domain-containing protein 2hSNU114 | nucleolar GTP-binding protein 2autoantigen NGP-1guanine nucleotide binding protein-like 2 (nucleolar)novel nucleolar guanosine 5'-triphosphate binding protein autoantigennucleolar G-protein gene 1nucleolar GTPasenucleostemin-2 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q15029 | Q13823 | |
| Ensembl transtripts involved in fusion gene | ENST00000426333, ENST00000592576, ENST00000591382, ENST00000402521, ENST00000589211, | ENST00000373062, ENST00000462812, | |
| Fusion gene scores | * DoF score | 14 X 12 X 10=1680 | 4 X 4 X 2=32 |
| # samples | 15 | 4 | |
| ** MAII score | log2(15/1680*10)=-3.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: EFTUD2 [Title/Abstract] AND GNL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | EFTUD2(42956923)-GNL2(38042157), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | EFTUD2-GNL2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. EFTUD2-GNL2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | EFTUD2 | GO:0000398 | mRNA splicing, via spliceosome | 28076346 |
| Fusion gene breakpoints across EFTUD2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across GNL2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | ESCA | TCGA-LN-A4MR | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
Top |
Fusion Gene ORF analysis for EFTUD2-GNL2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000426333 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| 5CDS-intron | ENST00000426333 | ENST00000462812 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| Frame-shift | ENST00000592576 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| 5CDS-intron | ENST00000592576 | ENST00000462812 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| In-frame | ENST00000591382 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| 5CDS-intron | ENST00000591382 | ENST00000462812 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| In-frame | ENST00000402521 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| 5CDS-intron | ENST00000402521 | ENST00000462812 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| intron-3CDS | ENST00000589211 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| intron-intron | ENST00000589211 | ENST00000462812 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000591382 | EFTUD2 | chr17 | 42956923 | - | ENST00000373062 | GNL2 | chr1 | 38042157 | - | 2426 | 1100 | 398 | 2386 | 662 |
| ENST00000402521 | EFTUD2 | chr17 | 42956923 | - | ENST00000373062 | GNL2 | chr1 | 38042157 | - | 2000 | 674 | 62 | 1960 | 632 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000591382 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - | 0.002005132 | 0.9979949 |
| ENST00000402521 | ENST00000373062 | EFTUD2 | chr17 | 42956923 | - | GNL2 | chr1 | 38042157 | - | 0.004834718 | 0.9951652 |
Top |
Fusion Genomic Features for EFTUD2-GNL2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EFTUD2-GNL2 |
| Go to FGviewer for the breakpoints of chr17:42956923-chr1:38042157 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| EFTUD2 | GNL2 |
| FUNCTION: Required for pre-mRNA splicing as component of the spliceosome, including pre-catalytic, catalytic and post-catalytic spliceosomal complexes (PubMed:28502770, PubMed:28781166, PubMed:28076346, PubMed:29361316, PubMed:30315277, PubMed:29360106, PubMed:29301961, PubMed:30705154). Component of the U5 snRNP and the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome (PubMed:16723661). {ECO:0000269|PubMed:16723661, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30315277, ECO:0000269|PubMed:30705154}. | FUNCTION: GTPase that associates with pre-60S ribosomal subunits in the nucleolus and is required for their nuclear export and maturation (By similarity). May promote cell proliferation possibly by increasing p53/TP53 protein levels, and consequently those of its downstream product CDKN1A/p21, and decreasing RPL23A protein levels (PubMed:26203195). {ECO:0000250, ECO:0000269|PubMed:26203195}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000402521 | - | 8 | 27 | 136_143 | 199.0 | 938.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000426333 | - | 9 | 28 | 136_143 | 234.0 | 973.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000426333 | - | 9 | 28 | 204_208 | 234.0 | 973.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000591382 | - | 9 | 28 | 136_143 | 234.0 | 973.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000591382 | - | 9 | 28 | 204_208 | 234.0 | 973.0 | Nucleotide binding | GTP |
| Tgene | GNL2 | chr17:42956923 | chr1:38042157 | ENST00000373062 | 7 | 16 | 565_571 | 303.0 | 732.0 | Compositional bias | Note=Poly-Glu | |
| Tgene | GNL2 | chr17:42956923 | chr1:38042157 | ENST00000373062 | 7 | 16 | 317_324 | 303.0 | 732.0 | Nucleotide binding | GTP | |
| Tgene | GNL2 | chr17:42956923 | chr1:38042157 | ENST00000373062 | 7 | 16 | 361_365 | 303.0 | 732.0 | Nucleotide binding | GTP |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000402521 | - | 8 | 27 | 127_409 | 199.0 | 938.0 | Domain | tr-type G |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000426333 | - | 9 | 28 | 127_409 | 234.0 | 973.0 | Domain | tr-type G |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000591382 | - | 9 | 28 | 127_409 | 234.0 | 973.0 | Domain | tr-type G |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000402521 | - | 8 | 27 | 204_208 | 199.0 | 938.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000402521 | - | 8 | 27 | 258_261 | 199.0 | 938.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000426333 | - | 9 | 28 | 258_261 | 234.0 | 973.0 | Nucleotide binding | GTP |
| Hgene | EFTUD2 | chr17:42956923 | chr1:38042157 | ENST00000591382 | - | 9 | 28 | 258_261 | 234.0 | 973.0 | Nucleotide binding | GTP |
| Tgene | GNL2 | chr17:42956923 | chr1:38042157 | ENST00000373062 | 7 | 16 | 207_368 | 303.0 | 732.0 | Domain | CP-type G |
Top |
Fusion Gene Sequence for EFTUD2-GNL2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000591382_ENST00000373062_TCGA-LN-A4MR_EFTUD2_chr17_42956923_-_GNL2_chr1_38042157_length(transcript)=2426nt_BP=1100nt GTAAGTTGAAGCGGGTCAGCGGCACGGAAGGGTTGCTCCAGGTGGGATAGGAAATTAAAAAGCGTCAGATCTGGAAGGGGCCTTATATGC TATTGGCCCCTTTCGCTTTACGGATCGGTAAATTGAGGCCTGGAGCGGGAAAAAGAATGGAAGACCCTGTCGTCCTCGTGCCTTCCCAAG GCTTCCGAAGCGCGCACACACGCACACACCTCGATTTCGGGGCTGCCTCTATAGCCTCAGTCCGTAAAATCGTATCGCTAGGTAGGAGTG GTGCTCTAACTGTCCAGTCCCCTCGCTCACTTCCTCTTCTATCCGTGCCGCTTTCAGCCGTTCTTTGCCAAGTTCCCTCCGAAGTCCTCT GAGCTCCTGCATTGTAGCGGGAAGCGGCAGTGAGCATCATGGATACCGACTTATATGATGAGTTTGGGAATTATATTGGACCAGAGCTTG ATTCTGATGAAGATGATGATGAATTGGGTAGAGAGACCAAAGATCTTGATGAGATGGATGATGATGACGACGACGATGACGTAGGAGATC ATGACGATGACCACCCTGGGATGGAGGTGGTGCTGCATGAGGACAAGAAGTACTACCCAACAGCCGAGGAGGTGTATGGTCCTGAGGTGG AGACCATAGTTCAAGAGGAAGACACTCAGCCTCTCACAGAACCCATTATTAAGCCAGTGAAAACCAAGAAATTCACTCTGATGGAGCAGA CATTACCTGTTACGGTGTATGAGATGGATTTCTTGGCGGATCTGATGGATAACTCAGAGCTCATCAGAAATGTGACCCTTTGTGGACATC TCCACCATGGCAAGACATGTTTTGTGGATTGTTTAATTGAACAGACTCACCCGGAAATCAGAAAGCGCTATGACCAAGATCTGTGCTATA CTGACATCCTCTTCACAGAGCAAGAGAGAGGTGTAGGCATCAAAAGCACTCCTGTGACAGTGGTCTTGCCAGACACCAAAGGAAAATCTT ATCTCTTCAATATCATGGACACTCCAGGACATGTGAATTTCTCTGATGAGGTCACAGCTGGCTTGCGCATCTCAGATGGAGTGGTCCTTT TCATTGATGCTGCTGAGGGGTTGCACACTGACAAGAAACAGATCAGTGTTGGGTTCATTGGCTATCCAAATGTTGGCAAGAGCTCTGTGA TAAATACATTGCGTTCTAAGAAAGTTTGCAACGTGGCTCCCATTGCAGGTGAAACAAAGGTCTGGCAGTATATTACTTTGATGCGTCGGA TATTCCTGATTGACTGTCCAGGTGTGGTTTACCCCTCTGAGGACTCCGAGACAGACATTGTGCTAAAAGGAGTTGTTCAAGTAGAAAAAA TTAAGAGTCCTGAAGACCACATTGGTGCTGTACTTGAACGAGCAAAGCCAGAATATATCAGCAAAACATACAAGATTGATTCTTGGGAGA ATGCTGAGGACTTTCTTGAGAAGCTCGCTTTCCGGACTGGGAAGTTACTAAAGGGTGGAGAGCCCGACTTGCAGACTGTGGGTAAGATGG TCCTCAATGACTGGCAGAGGGGCCGGATTCCTTTCTTTGTCAAGCCACCCAATGCAGAGCCACTTGTGGCCCCCCAGCTTCTACCCTCCT CATCTTTGGAAGTTGTCCCAGAAGCAGCCCAGAACAATCCAGGGGAGGAAGTCACAGAAACTGCAGGTGAAGGGTCAGAATCCATCATTA AGGAAGAAACAGAAGAGAACAGTCACTGTGATGCTAACACAGAGATGCAGCAGATTCTCACACGAGTTCGGCAGAACTTTGGTAAAATCA ACGTGGTGCCTCAGTTTTCTGGGGATGACCTGGTTCCTGTGGAGGTGTCAGATCTTGAGGAAGAGCTTGAGAGCTTTTCTGATGAAGAGG AGGAGGAACAGGAGCAACAAAGAGATGATGCGGAAGAGTCTTCCTCGGAGCCTGAGGAGGAAAATGTGGGAAACGACACCAAAGCCGTTA TTAAAGCACTGGATGAGAAGATTGCCAAATATCAGAAGTTTCTAGACAAAGCCAAAGCCAAAAAGTTTTCAGCAGTCAGAATATCCAAGG GACTGAGTGAAAAGATATTTGCAAAACCTGAAGAACAAAGAAAAACACTGGAAGAAGATGTAGATGACAGAGCACCTTCCAAAAAGGGAA AGAAGCGGAAGGCACAAAGGGAAGAGGAACAGGAACATTCAAATAAAGCTCCCAGGGCGCTTACATCAAAAGAACGGAGGCGAGCAGTAC GACAGCAACGGCCGAAAAAAGTTGGTGTGCGCTACTATGAAACACACAACGTGAAAAATAGGAACAGGAACAAAAAGAAGACCAATGACT >In-frame_ENST00000591382_ENST00000373062_TCGA-LN-A4MR_EFTUD2_chr17_42956923_-_GNL2_chr1_38042157_length(amino acids)=662AA_start in transcript=398_stop in transcript=2386 MDTDLYDEFGNYIGPELDSDEDDDELGRETKDLDEMDDDDDDDDVGDHDDDHPGMEVVLHEDKKYYPTAEEVYGPEVETIVQEEDTQPLT EPIIKPVKTKKFTLMEQTLPVTVYEMDFLADLMDNSELIRNVTLCGHLHHGKTCFVDCLIEQTHPEIRKRYDQDLCYTDILFTEQERGVG IKSTPVTVVLPDTKGKSYLFNIMDTPGHVNFSDEVTAGLRISDGVVLFIDAAEGLHTDKKQISVGFIGYPNVGKSSVINTLRSKKVCNVA PIAGETKVWQYITLMRRIFLIDCPGVVYPSEDSETDIVLKGVVQVEKIKSPEDHIGAVLERAKPEYISKTYKIDSWENAEDFLEKLAFRT GKLLKGGEPDLQTVGKMVLNDWQRGRIPFFVKPPNAEPLVAPQLLPSSSLEVVPEAAQNNPGEEVTETAGEGSESIIKEETEENSHCDAN TEMQQILTRVRQNFGKINVVPQFSGDDLVPVEVSDLEEELESFSDEEEEEQEQQRDDAEESSSEPEEENVGNDTKAVIKALDEKIAKYQK FLDKAKAKKFSAVRISKGLSEKIFAKPEEQRKTLEEDVDDRAPSKKGKKRKAQREEEQEHSNKAPRALTSKERRRAVRQQRPKKVGVRYY -------------------------------------------------------------- >In-frame_ENST00000402521_ENST00000373062_TCGA-LN-A4MR_EFTUD2_chr17_42956923_-_GNL2_chr1_38042157_length(transcript)=2000nt_BP=674nt GCAGGCGTTTCCTCGGCGTGGGGCGGAAGCACGATCTCCGGCAGCGGCCTGGGAACTCTTAGCTGAGCAGGCGAGAGATGGATGATGATG ACGACGACGATGACGTAGGAGATCATGACGATGACCACCCTGGGATGGAGGTGGTGCTGCATGAGGACAAGAAGTACTACCCAACAGCCG AGGAGGTGTATGGTCCTGAGGTGGAGACCATAGTTCAAGAGGAAGACACTCAGCCTCTCACAGAACCCATTATTAAGCCAGTGAAAACCA AGAAATTCACTCTGATGGAGCAGACATTACCTGTTACGGTGTATGAGATGGATTTCTTGGCGGATCTGATGGATAACTCAGAGCTCATCA GAAATGTGACCCTTTGTGGACATCTCCACCATGGCAAGACATGTTTTGTGGATTGTTTAATTGAACAGACTCACCCGGAAATCAGAAAGC GCTATGACCAAGATCTGTGCTATACTGACATCCTCTTCACAGAGCAAGAGAGAGGTGTAGGCATCAAAAGCACTCCTGTGACAGTGGTCT TGCCAGACACCAAAGGAAAATCTTATCTCTTCAATATCATGGACACTCCAGGACATGTGAATTTCTCTGATGAGGTCACAGCTGGCTTGC GCATCTCAGATGGAGTGGTCCTTTTCATTGATGCTGCTGAGGGGTTGCACACTGACAAGAAACAGATCAGTGTTGGGTTCATTGGCTATC CAAATGTTGGCAAGAGCTCTGTGATAAATACATTGCGTTCTAAGAAAGTTTGCAACGTGGCTCCCATTGCAGGTGAAACAAAGGTCTGGC AGTATATTACTTTGATGCGTCGGATATTCCTGATTGACTGTCCAGGTGTGGTTTACCCCTCTGAGGACTCCGAGACAGACATTGTGCTAA AAGGAGTTGTTCAAGTAGAAAAAATTAAGAGTCCTGAAGACCACATTGGTGCTGTACTTGAACGAGCAAAGCCAGAATATATCAGCAAAA CATACAAGATTGATTCTTGGGAGAATGCTGAGGACTTTCTTGAGAAGCTCGCTTTCCGGACTGGGAAGTTACTAAAGGGTGGAGAGCCCG ACTTGCAGACTGTGGGTAAGATGGTCCTCAATGACTGGCAGAGGGGCCGGATTCCTTTCTTTGTCAAGCCACCCAATGCAGAGCCACTTG TGGCCCCCCAGCTTCTACCCTCCTCATCTTTGGAAGTTGTCCCAGAAGCAGCCCAGAACAATCCAGGGGAGGAAGTCACAGAAACTGCAG GTGAAGGGTCAGAATCCATCATTAAGGAAGAAACAGAAGAGAACAGTCACTGTGATGCTAACACAGAGATGCAGCAGATTCTCACACGAG TTCGGCAGAACTTTGGTAAAATCAACGTGGTGCCTCAGTTTTCTGGGGATGACCTGGTTCCTGTGGAGGTGTCAGATCTTGAGGAAGAGC TTGAGAGCTTTTCTGATGAAGAGGAGGAGGAACAGGAGCAACAAAGAGATGATGCGGAAGAGTCTTCCTCGGAGCCTGAGGAGGAAAATG TGGGAAACGACACCAAAGCCGTTATTAAAGCACTGGATGAGAAGATTGCCAAATATCAGAAGTTTCTAGACAAAGCCAAAGCCAAAAAGT TTTCAGCAGTCAGAATATCCAAGGGACTGAGTGAAAAGATATTTGCAAAACCTGAAGAACAAAGAAAAACACTGGAAGAAGATGTAGATG ACAGAGCACCTTCCAAAAAGGGAAAGAAGCGGAAGGCACAAAGGGAAGAGGAACAGGAACATTCAAATAAAGCTCCCAGGGCGCTTACAT CAAAAGAACGGAGGCGAGCAGTACGACAGCAACGGCCGAAAAAAGTTGGTGTGCGCTACTATGAAACACACAACGTGAAAAATAGGAACA GGAACAAAAAGAAGACCAATGACTCAGAGGGACAGAAACACAAACGCAAAAAATTCAGACAAAAGCAGTAATGTTTAAAAGGTTTTTATT >In-frame_ENST00000402521_ENST00000373062_TCGA-LN-A4MR_EFTUD2_chr17_42956923_-_GNL2_chr1_38042157_length(amino acids)=632AA_start in transcript=62_stop in transcript=1960 MSRREMDDDDDDDDVGDHDDDHPGMEVVLHEDKKYYPTAEEVYGPEVETIVQEEDTQPLTEPIIKPVKTKKFTLMEQTLPVTVYEMDFLA DLMDNSELIRNVTLCGHLHHGKTCFVDCLIEQTHPEIRKRYDQDLCYTDILFTEQERGVGIKSTPVTVVLPDTKGKSYLFNIMDTPGHVN FSDEVTAGLRISDGVVLFIDAAEGLHTDKKQISVGFIGYPNVGKSSVINTLRSKKVCNVAPIAGETKVWQYITLMRRIFLIDCPGVVYPS EDSETDIVLKGVVQVEKIKSPEDHIGAVLERAKPEYISKTYKIDSWENAEDFLEKLAFRTGKLLKGGEPDLQTVGKMVLNDWQRGRIPFF VKPPNAEPLVAPQLLPSSSLEVVPEAAQNNPGEEVTETAGEGSESIIKEETEENSHCDANTEMQQILTRVRQNFGKINVVPQFSGDDLVP VEVSDLEEELESFSDEEEEEQEQQRDDAEESSSEPEEENVGNDTKAVIKALDEKIAKYQKFLDKAKAKKFSAVRISKGLSEKIFAKPEEQ RKTLEEDVDDRAPSKKGKKRKAQREEEQEHSNKAPRALTSKERRRAVRQQRPKKVGVRYYETHNVKNRNRNKKKTNDSEGQKHKRKKFRQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EFTUD2-GNL2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EFTUD2-GNL2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EFTUD2-GNL2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | EFTUD2 | C1864652 | Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | EFTUD2 | C0152423 | Congenital small ears | 1 | GENOMICS_ENGLAND |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies